Stockreport

Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGF...

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF BLA Filing Based on HARMONi Global Phase III Study ResultsPDUFA Goal Action Date of November 14, 2026Significant Unmet Need Remains; Over 14,000 U.S. Patients Eligible f [Read more]